Temodar Lyophilisate For Solution For Injection 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

TEMODAR: Lyophilisate for solution for injection (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

TEMOZOLOMIDE (te moe ZOE loe mide) is a chemotherapy drug. It is used to treat some kinds of brain cancer.

In-Depth Information

TEMODAR 100mg Powder for Injection

NDC: 000851381
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Glioblastoma Multiforme, Astrocytoma

Storage Information
Store unreconstituted product in refrigerator (36 to 46 degrees F)
Reconstituted product must be used within 14 hours including infusion time
Store reconstituted product at room temperature (77 degrees F)
TEMODAR 100mg Powder for Injection

Reported Side Effects for TEMODAR 100mg Powder for Injection

Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Dry Skin Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stomach Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
<6.0%*
Severity: SEVERE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Memory Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Confusion Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: EARLY
Blurred Vision Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Skin Redness Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Loose Stools Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Difficulty Swallowing Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
1.0-10.0%*
Severity: SEVERE
Onset: EARLY
Nervousness Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Paresthesias Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Uncontrolled Urination Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Headache Incidence:
2.0-6.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Weakness Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Incoordination Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Fever Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Drowsiness Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Paresis Incidence:
3.0-6.0%*
Severity: SEVERE
Onset: DELAYED
Back Pain Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Loss Of Memory Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
4.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Tired Incidence:
4.0-9.0%*
Severity: SEVERE
Onset: EARLY
Inability To Sleep Incidence:
4.0-10.0%*
Severity: MILD
Onset: EARLY
Double Vision Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
5.0-6.0%*
Severity: MILD
Onset: EARLY
Visual Impairment Incidence:
5.0%*
Severity: SEVERE
Onset: EARLY
Weight Gain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Muscle Pain Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
6.0-23.0%*
Severity: SEVERE
Onset: DELAYED
Increased Urination Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Infection Incidence:
6.0-11.0%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Breast Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Cushing's Syndrome Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Sore Throat Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
8.0-14.0%*
Severity: SEVERE
Onset: DELAYED
Low Lymphocytes Incidence:
55.0%*
Severity: SEVERE
Onset: DELAYED
Hair Loss Incidence:
55.0-69.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with TEMODAR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5